Frontiers in Pharmacology (Nov 2019)

Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma

  • Chongyang Wang,
  • Chongyang Wang,
  • Mingyu Zheng,
  • Mingyu Zheng,
  • Yunho Choi,
  • Jingzhi Jiang,
  • Jingzhi Jiang,
  • Li Li,
  • Li Li,
  • Junfeng Li,
  • Junfeng Li,
  • Chang Xu,
  • Chang Xu,
  • Zhemin Xian,
  • Zhemin Xian,
  • Yan Li,
  • Yan Li,
  • Hongmei Piao,
  • Hongmei Piao,
  • Liangchang Li,
  • Liangchang Li,
  • Guanghai Yan,
  • Guanghai Yan

DOI
https://doi.org/10.3389/fphar.2019.01338
Journal volume & issue
Vol. 10

Abstract

Read online

The study is to investigate the effect of cryptotanshinone (CTS) on airway remodeling and the possible mechanism. Male BALB/c mice were pretreated with CTS or dexamethasone 30 min before nebulized inhalation of ovalbumin (OVA). CTS significantly inhibited OVA-induced increases of eosinophils and neutrophils infiltration of bronchoalveolar lavage fluids (BALFs), reduced airway resistance in asthmatic mice, decreased the accumulation of inflammatory cells, the hyperplasia of goblet cells and the deposition of collagen in asthmatic mice lung tissue, as well as markedly attenuated the leakage of inflammatory cells and the level of OVA-specific immunoglobulin E in BALFs. CTS also inhibited the expressions of alpha-smooth muscle actin, tumor necrosis factor-like weak inducer of apoptosis (TWEAK), Fn14, transforming growth factor (TGF)-β1, Smad4, and phosphorylation of Smad2/3 and STAT3 (Tyr705). In comparison to TWEAK inhibitor or TWEAK small interfering RNA (siRNA), which were used to inhibit TWEAK/STAT3 signaling pathways, CTS caused a similar effect as them on airway remodeling. Additionally, CTS also played a similar role as the TGF-β1 inhibitor or TGF-β1 siRNA in TGF-β1/STAT3 signaling pathways in airway remodeling. The anti-inflammatory effects of CTS against OVA-induced airway remodeling may be through inhibiting STAT3, which further suppresses TWEAK and TGF-β1 signaling cross talk in asthma. CTS may be a promising therapeutic reagent for asthma treatment.

Keywords